TRD management refers to the ongoing evaluation, treatment, and monitoring of Treatment-Resistant Depression (TRD). Treatment-resistant depression occurs when an individual does not experience adequate symptom improvement after trying at least two antidepressant medications at appropriate doses and durations. Because TRD can be complex, effective management often requires a comprehensive and individualized treatment approach.
The goal of TRD management is to reduce depression symptoms, improve daily functioning, achieve long-term remission, and enhance overall quality of life.
TRD management begins with a comprehensive psychiatric evaluation to understand an individual’s symptoms, previous treatment history, medical conditions, and overall mental health needs. Providers then develop a personalized treatment plan based on these findings.
TRD management may involve:
Because every individual responds differently to treatment, management plans are continually reviewed and adjusted over time.
TRD management may be appropriate for individuals who:
A comprehensive psychiatric evaluation is necessary to determine whether an individual has treatment-resistant depression and which management strategies are most appropriate.
Several evidence-based treatments may be incorporated into a TRD management plan.
Providers may adjust current medications, change antidepressants, combine medications, or prescribe augmentation therapies to improve symptom control.
Psychotherapy helps individuals develop coping strategies, process emotions, and address underlying factors contributing to depression.
TMS therapy is a non-invasive, FDA-cleared treatment that uses magnetic stimulation to target areas of the brain involved in mood regulation. TMS is commonly used for treatment-resistant depression.
Spravato® (esketamine) is FDA-approved for adults with treatment-resistant depression and may be recommended when traditional treatments have not been effective.
Healthy lifestyle habits such as regular exercise, stress management, healthy sleep patterns, and social support may complement professional treatment.
Comprehensive TRD management may provide several benefits, including:
Many individuals benefit from combining multiple treatment approaches as part of an integrated care plan.
At Pinnacle Behavioral Healthcare, we provide comprehensive TRD management services designed to help individuals experiencing treatment-resistant depression achieve meaningful symptom improvement. Our experienced providers offer Medication Management, Individual Psychotherapy, Pinnacle TMS, and Spravato Therapy as part of our personalized treatment approach.
We closely monitor treatment progress and adjust care plans as needed to support long-term wellness and recovery.
If previous depression treatments have not provided adequate relief, schedule a consultation with our team to discuss your treatment options.
TRD stands for Treatment-Resistant Depression, a form of depression in which symptoms do not adequately improve after treatment with at least two antidepressant medications.
TRD management refers to the ongoing evaluation, treatment, monitoring, and adjustment of care for individuals experiencing treatment-resistant depression.
TRD management may include medication management, psychotherapy, TMS therapy, Spravato® therapy, lifestyle interventions, and ongoing symptom monitoring.
Yes. Many individuals with treatment-resistant depression experience significant symptom improvement through comprehensive, individualized treatment plans and advanced therapies.
Ongoing monitoring allows providers to evaluate treatment effectiveness, identify symptom changes early, adjust treatment plans, and support long-term recovery.
